John Schoggins

John Schoggins

University of Texas Southwestern Medical Center

H-index: 42

North America-United States

About John Schoggins

John Schoggins, With an exceptional h-index of 42 and a recent h-index of 32 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center,

His recent articles reflect a diverse array of research interests and contributions to the field:

West Nile virus encephalitis presenting with a vesicular dermatitis

Positive‐strand RNA viruses—a Keystone Symposia report

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo

Identification of FDA Approved Drugs with Antiviral Activity against SARS-CoV-2: A Tale from structure-based drug repurposing to host-cell mechanistic investigation

Interferon inhibits a model RNA virus via a limited set of inducible effector genes

CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication

LY6E is a pan-coronavirus restriction factor in the respiratory tract

Virology under the microscope—a call for rational discourse

John Schoggins Information

University

Position

___

Citations(all)

12788

Citations(since 2020)

7372

Cited By

7999

hIndex(all)

42

hIndex(since 2020)

32

i10Index(all)

58

i10Index(since 2020)

51

Email

University Profile Page

University of Texas Southwestern Medical Center

Google Scholar

View Google Scholar Profile

Top articles of John Schoggins

Title

Journal

Author(s)

Publication Date

West Nile virus encephalitis presenting with a vesicular dermatitis

JAAD Case Reports

Eunice E Lee

Maria Mejia

Loderick A Matthews

Francesca Lee

Kishan M Shah

...

2024/1/7

Positive‐strand RNA viruses—a Keystone Symposia report

Annals of the New York Academy of Sciences

Jennifer Cable

Mark R Denison

Margaret Kielian

William T Jackson

Ralf Bartenschlager

...

2023/3

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo

bioRxiv

Daniel L Kober

Marley C Caballero Van Dyke

Jennifer L Eitson

Ian N Boys

Matthew B McDougal

...

2023/10/5

Identification of FDA Approved Drugs with Antiviral Activity against SARS-CoV-2: A Tale from structure-based drug repurposing to host-cell mechanistic investigation

Biomedicine & pharmacotherapy= Biomedecine & pharmacotherapie

Mahmoud S Ahmed

Ayman B Farag

Ian N Boys

Ping Wang

Ivan Menendez-Montes

...

2023

Interferon inhibits a model RNA virus via a limited set of inducible effector genes

EMBO reports

Matthew B McDougal

Anthony M De Maria

Maikke B Ohlson

Ashwani Kumar

Chao Xing

...

2023/9/6

CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication

Cell Reports

Frederick Rehfeld

Jennifer L Eitson

Maikke B Ohlson

Tsung-Cheng Chang

John W Schoggins

...

2023/2/28

LY6E is a pan-coronavirus restriction factor in the respiratory tract

Nature microbiology

Katrina B Mar

Alexandra I Wells

Marley C Caballero Van Dyke

Alexandra H Lopez

Jennifer L Eitson

...

2023/8

Virology under the microscope—a call for rational discourse

Journal of virology

Felicia Goodrum

Anice C Lowen

Seema Lakdawala

James Alwine

Arturo Casadevall

...

2023/2/28

LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2

bioRxiv

Katrina B Mar

Marley C Van Dyke

Alexandra H Lopez

Jennifer L Eitson

Wenchun Fan

...

2023/1/26

FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms

Biomedicine & Pharmacotherapy

Mahmoud S Ahmed

Ayman B Farag

Ian N Boys

Ping Wang

Ivan Menendez-Montes

...

2023/6/1

A concerted mechanism involving ACAT and SREBPs by which oxysterols deplete accessible cholesterol to restrict microbial infection

Elife

David B Heisler

Kristen A Johnson

Duo H Ma

Maikke B Ohlson

Lishu Zhang

...

2023/1/25

Genome-scale CRISPR screening reveals host factors required for ribosome formation and viral replication

Mbio

Maikke B Ohlson

Jennifer L Eitson

Alexandra I Wells

Ashwani Kumar

Seoyeon Jang

...

2023/4/25

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection

PLoS pathogens

Grace P Carreno-Florez

Brian R Kocak

Matthew R Hendricks

Jeffrey A Melvin

Katrina B Mar

...

2023/11/8

The mechanism of RNA capping by SARS-CoV-2 (preprint)

Gina Park

Adam Osinski

Genaro Hernandez

Jennifer Eitson

Abir Majumdar

...

2022

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial

Frontiers in pharmacology

Mamta K Jain

James A De Lemos

Darren K McGuire

Colby Ayers

Jennifer L Eitson

...

2022/9/30

The mechanism of RNA capping by SARS-CoV-2

Nature

Gina J Park

Adam Osinski

Genaro Hernandez

Jennifer L Eitson

Abir Majumdar

...

2022/9/22

The use of mebendazole in COVID-19 patients: An observational retrospective single center study

Advances in Virology

Mostafa W Galal

Mahmoud Ahmed

Yanqiu Shao

Chao Xing

Wael Ali

...

2022/12/10

252 West Nile Virus presenting as a bullous dermatosis with evidence for keratinocyte involvement in viral replication

Journal of Investigative Dermatology

E Lee

L Matthews

K Shah

F Lee

J Schoggins

...

2022/8/1

A Multi-Omics Approach Reveals Features That Permit Robust and Widespread Regulation of IFN-Inducible Antiviral Effectors

The Journal of Immunology

Loránd Göczi

Mária Csumita

Attila Horváth

Gergely Nagy

Szilárd Póliska

...

2022/11/15

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

PLoS Computational Biology

Ryuichi Kumata

Shoya Iwanami

Katrina B Mar

Yusuke Kakizoe

Naoko Misawa

...

2022/4/25

See List of Professors in John Schoggins University(University of Texas Southwestern Medical Center)